Rasio Total Utang marang Ekuitas Model N Inc (MODN)

MODN (Model N) - tandha merek perusahaan

Model N, Inc. (MODN) develops secure cloud software within the legal frameworks of the US and EU, remaining insulated from geopolitical turmoil. The business leverages the high stickiness of pharmaceutical companies to its SaaS solutions, generating stable subscription revenue. This price chart, which assists in the asset's fundamental valuation, shows that the individual debt-to-equity ratio is 0.00. However, lengthy deal cycles and a potential revision of corporate IT spending create certain risks for revenue growth rates.

MODN Rasio Kabeh Utang marang Dana Pribadi Model N (04.07.2022 - 06.07.2024)

Rincian analitis lan laporan data perusahaan Model N Corporation (MODN)

- rega lan prakiraan konsensus rega:
Rega saham Model N|MODN - Target median analis
- data kapitalisasi pasar:
Biji pasar Model N|MODN - Total Nilai Bisnis
- data kapitalisasi buku:
Nilai Akuntansi saben Saham Model N|MODN - Nilai Akuntansi Perusahaan|Rasio Nilai Pasar marang Nilai Buku modeln.com|MODN - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Model N, Inc.|MODN - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Model N, Inc.|MODN - Utang agregat perusahaan|Rasio utang marang kapitalisasi buku Model N
Ringkesan analisis perusahaan:Model N
Sampel barang Model N Corporation

This ratio compares total credit obligations to net assets, determining the business's degree of dependence on external financing and its level of financial stability. By analyzing the historical debt-to-equity ratio, an investor can assess how effectively Model N, Inc. (MODN) utilizes leverage amidst high loyalty from pharmaceutical clients, which provides the company with a stable cash flow and minimizes default risks.

Pesaing wigati

VEEV: Total Utang marang Modal|Koefisien Total Utang marang Modal Doximity Inc (DOCS)|Rasio Total Utang marang Ekuitas HealthEquity Corp|Utang Agregat marang Modal Waystar Corp WAY|Rasio Total Utang marang Ekuitas CorVel Corporation|priviahealth.com - Rasio Kabeh Utang marang Dana Pribadi|HURN: Utang marang Ekuitas|CERT - Rasio Total Utang marang Ekuitas|Total Utang marang Modal OMCL|GoodRx Gold (GDRX) - Utang marang Modal|Total Utang marang Modal Schrodinger, Inc. (SDGR)|Rasio Utang marang Ekuitas PHR|Utang marang Ekuitas OMDA (Omada Health)|Rasio Total Utang marang Ekuitas EVH (Evolent Health Inc)|HSTM: Utang marang Ekuitas|Utang marang Modal Definitive Corp DH|Consensus Cloud Solutions (CCSI) - Total Utang marang Modal|AGL - Rasio Utang marang Ekuitas|Total Utang marang Modal ABSI|SY (So-Young International Inc) - Utang marang Modal|Utang marang Ekuitas National Research|Utang marang Ekuitas USA Mobility (SPOK)|OptimizeRx Corporation (OPRX) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi TBRG (trubridge.com)|SLP - Utang marang Ekuitas|SOPH - Rasio Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Health Catalyst, Inc (HCAT)|CCLD - Rasio Kabeh Utang marang Dana Pribadi|Research Solutions - Total Utang marang Modal|DLHC (DLH Holdings) - Koefisien Total Utang marang Modal|Utang marang Ekuitas OneMedNet Corp (ONMD)|Rasio Utang marang Ekuitas Scienture Holdings|Total Utang marang Modal HCTI (Healthcare Triangle Corp)|Rasio Total Utang marang Ekuitas ispecimen.com ISPC|Rasio Total Utang marang Ekuitas BFRG|scworx.com - Koefisien Total Utang marang Modal|MSPR: Utang marang Ekuitas|ICCT: Rasio Total Utang marang Ekuitas|Utang marang Ekuitas MEDS|Orgenesis Corporation (ORGS) - Utang marang Modal|Total Utang marang Modal R1 RCM, Inc. (RCM)|Rasio Utang marang Ekuitas SHCR|Utang marang Ekuitas Streamline Health STRM|Rasio Utang marang Ekuitas Syra Health Corp (SYRA)|Total Utang marang Modal AMEH|NXGN - Koefisien Total Utang marang Modal